Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
5.5 EUR | -1.08% | -5.82% | -37.07% |
May. 07 | Talea Group launches its private label branded Farmaè | AN |
Apr. 23 | Talea closes first quarter with revenues up | AN |
Summary
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company shows low valuation levels, with an enterprise value at 0.43 times its sales.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The company's sales previsions for the coming years have been revised downwards, which foreshadows another slowdown in business.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
Ratings chart - Surperformance
Sector: Internet Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-37.07% | 41.03M | - | ||
+9.15% | 206B | C- | ||
-3.96% | 195B | C | ||
+48.84% | 97B | B | ||
+6.73% | 85.04B | B | ||
-24.54% | 75.75B | B- | ||
+11.41% | 52.49B | B- | ||
+19.19% | 26.33B | B- | ||
+30.24% | 11.04B | B+ | ||
-5.35% | 9.12B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- FAR Stock
- Ratings Talea Group S.p.A.